MedPage Today15 天
One CAR T-Cell Therapy for Multiple Myeloma Tops Another in Propensity Matched Study
Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window SAN DIEGO -- In a propensity-matched comparison of two CAR T-cell therapies, ciltacabtagene autoleucel (cilta-cel ...
来自MSN14 天
One CAR T-Cell Therapy for Multiple Myeloma Tops Another in Propensity Matched Study
In a propensity-matched comparison of two CAR T-cell therapies, ciltacabtagene autoleucel (cilta-cel, Carvykti) demonstrated better efficacy than idecabtagene vicleucel (ide-cel, Abecma) for ...